J&J’s hip suit hit less painful than initially rumored
This article was originally published in Clinica
Executive Summary
Johnson & Johnson has announced that its DePuy Orthopaedics business is paying around $2.5bn to settle lawsuits related to the highly publicized recall of its ASR hip implants. This amount, while significant, should be a less painful blow for the healthcare giant than the $4bn it was rumored to be paying, according to media reports last week.
You may also be interested in...
Patients Awarded $1bn In J&J Ultamet Hip Lawsuit
The bellwether case resulted in a jury award of $1b to a group of six California patients who say they were injured by the metal-on-metal hip. J&J plans to appeal.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.